Paul Moraviec should not be confused with Paul Moravec.
Paul Moraviec | |
Nationality: | British |
Education: | Kingston University |
Occupation: | Businessman |
CEO, Convatec | |
Term: | April 2015-October 2018 |
Paul Moraviec (born April 1958)[1] is a British businessman. He was the chief executive officer (CEO) of Convatec, an international medical products and technologies company, listed on the FTSE 100 Index, from April 2015 to October 2018.[2]
Moraviec has a master's degree in marketing from London's Kingston University Business School.[3]
Before joining Convatec, he was vice president, neurosurgery business at Johnson & Johnson, and vice president, international commercialoperations at Abbott Laboratories.[4]
Convatec announced that Moraviec will be retiring with immediate effect on 15 October 2018, and will be succeeded on an interim basis by non-executive director Rick Anderson, who was formerly the chairman of Johnson & Johnson.[5]